14 results on '"Kudrik, Fred J."'
Search Results
2. Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)
3. Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease
4. Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer
5. Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies
6. Hypersensitivity Pneumonitis in Advanced Non-Small-Cell Lung Cancer Patients Receiving Gemcitabine and Paclitaxel: Report of Two Cases and a Review of the Literature
7. PARPi monotherapy as first-line maintenance following chemotherapy + bevacizumab in advanced ovarian cancer.
8. Real-world outcomes of first-line maintenance with niraparib or bevacizumab in advanced ovarian cancer.
9. Understanding differences in the rates of BRCA/HRD testing and treatment in 1 st line maintenance in patients with ovarian cancer treated by gynecologic oncologists compared to other providers: A quality initiative by Integra Connect (IC) PrecisionQ.
10. Phase II trial of preoperative carboplatin (carbo)/pemetrexed (pem) in patients (pts) with select stage IB-IIIA nonsquamous non-small cell lung cancer (NS-NSCLC).
11. The burden of blood transfusion: a utilization and economic analysis – a pilot study in patients with chemotherapy-induced anemia (CIA)
12. A single-arm, open-label, U.S. expanded access study of vemurafenib in patients with metastatic melanoma.
13. The Burden of Blood Transfusion: A Utilization Analysis - A Pilot Study
14. Catastrophic antiphospholipid antibody Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.